HEATHER SULLIVAN: Open Payments
NPI 1750683967 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$998 in 21 payments from 8 companies in 2025. Trend: 2023 $18 · 2024 $359 · 2025 $998
Food & beverage: $998
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $304 |
| Neurocrine BioSciences, Inc. | 4 | $194 |
| Teva Pharmaceuticals USA, Inc. | 4 | $131 |
| Alkermes, Inc. | 1 | $125 |
| SI-BONE, INC. | 1 | $116 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Phadia US Inc. | 1 | $15 |
Products named: INVEGA SUSTENNA, INGREZZA, ARISTADA, UZEDY, CAPLYTA, AUSTEDO XR, REXULTI, ImmunoCAP.
Industry payments across AZ — which companies pay providers there.
